As seen in other types of neoplasms, p53 mutation is one of the most common changes observed in IPMN [30], which is often identified as abnormal immunostain [31, 32] and/or by mutational analysis. Here, TP53 is linked to pancreatic intraductal papillary-mucinous neoplasm.